PFIZER U.S. CARDURA SALES ARE $75.3 MIL. IN 1993 WITH BPH INDICATION IN OFFING; PROCARDIA XL FOURTH QUARTER SALES DROP ATTRIBUTED TO INVENTORY CHANGES
Executive Summary
Pfizer's U.S. sales of the alpha blocker Cardura increased by 56% to $75.3 mil. in 1993, Chief Financial Officer Henry McKinnell told a meeting of securities analysts Feb. 8 in New York City.